2021
Long‐acting and extended‐release implant and nanoformulations with a synergistic antiretroviral two‐drug combination controls HIV‐1 infection in a humanized mouse model
Beloor J, Kudalkar SN, Buzzelli G, Yang F, Mandl HK, Rajashekar JK, Spasov KA, Jorgensen WL, Saltzman WM, Anderson KS, Kumar P. Long‐acting and extended‐release implant and nanoformulations with a synergistic antiretroviral two‐drug combination controls HIV‐1 infection in a humanized mouse model. Bioengineering & Translational Medicine 2021, 7: e10237. PMID: 35079625, PMCID: PMC8780078, DOI: 10.1002/btm2.10237.Peer-Reviewed Original ResearchNucleoside reverse transcriptase inhibitorHIV-1 infectionAntiretroviral therapyHIV-1-infected humanized miceTwo-drug combinationsHumanized mouse modelLong-term treatmentReverse transcriptase inhibitorMaintenance of CD4Nonnucleoside reverseHumanized miceAntiretroviral formulationsAdherence issuesARV combinationsTranscriptase inhibitorHIV pandemicT cellsMouse modelInjectable nanoformulationsTherapeutic indexNew drugsSustained levelsInfectionDrugsIntervention
2011
Adapting an Evidence‐Based Intervention Targeting HIV‐Infected Prisoners in Malaysia
Copenhaver MM, Tunku N, Ezeabogu I, Potrepka J, Zahari MM, Kamarulzaman A, Altice FL. Adapting an Evidence‐Based Intervention Targeting HIV‐Infected Prisoners in Malaysia. AIDS Research And Treatment 2011, 2011: 131045. PMID: 21860786, PMCID: PMC3157158, DOI: 10.1155/2011/131045.Peer-Reviewed Original ResearchHIV riskHolistic Health Recovery ProgramHIV risk reduction interventionsHigh-risk populationRisk reduction interventionsTarget populationCritical target populationAntiretroviral therapyAdherence issuesTargeting HIVHIVReduction interventionsIntervention contentSubstance abuseFormative researchStructured interviewsFormative workFamily membersPrison settingRecovery programRiskPopulationTherapyCare
2009
Adaptation of an Evidence-Based Intervention Targeting HIV-Infected Prisoners Transitioning to the Community: The Process and Outcome of Formative Research for the Positive Living Using Safety (PLUS) Intervention
Copenhaver M, Chowdhury S, Altice FL. Adaptation of an Evidence-Based Intervention Targeting HIV-Infected Prisoners Transitioning to the Community: The Process and Outcome of Formative Research for the Positive Living Using Safety (PLUS) Intervention. AIDS Patient Care And STDs 2009, 23: 277-287. PMID: 19260773, PMCID: PMC2770798, DOI: 10.1089/apc.2008.0157.Peer-Reviewed Original ResearchConceptsEvidence-based interventionsFormative researchHolistic Health Recovery ProgramHigh-risk populationHIV risk profilesHIV risk reductionCommunity-based settingsTarget populationAntiretroviral therapyAdherence issuesTargeting HIVHIVReal-world settingRisk profileIntervention contentWeekly sessionsPrespecified topicsPositive livingGroup formatSafety interventionsRisk reductionCritical periodStructured interviewsCorrectional settingsIntervention
2002
Adherence to Therapy With Oral Antineoplastic Agents
Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to Therapy With Oral Antineoplastic Agents. Journal Of The National Cancer Institute 2002, 94: 652-661. PMID: 11983753, DOI: 10.1093/jnci/94.9.652.Peer-Reviewed Original ResearchConceptsOral antineoplastic agentsAntineoplastic agentsOral antineoplastic therapyOral anticancer agentsAssessment of adherenceStudy of adherencePrediction of adherenceImplementation of interventionsChemotherapy recommendationsOral medicationsPrescribed regimensClinical outcomesPatient adherencePediatric populationAdherence ratesPoor adherenceAntineoplastic therapyAdherence issuesClinical trialsCancer preventionPhysician's officeAdherence behaviorAvailable evidenceAdherenceCertain populations
2001
Patterns of Adherence With Antiretroviral Medications: An Examination of Between-Medication Differences.
Wilson IB, Tchetgen E, Spiegelman D. Patterns of Adherence With Antiretroviral Medications: An Examination of Between-Medication Differences. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 259. PMID: 11694833, DOI: 10.1097/00042560-200111010-00009.Peer-Reviewed Original ResearchConceptsAntiretroviral medicationsAdherence issuesPatient differencesLast weekMore antiretroviral medicationsPercent of patientsPatterns of adherencePatient adherence issuesRepeated-measurements analysisCohort studyHIV infectionAntiretroviral adherenceAdherence ratesMean ageOverall adherenceMedicationsPatientsAdherence patternsPerfect adherencePerson varianceDosing timeAdherenceWeeksDoseReliability coefficientsPatterns of Adherence With Antiretroviral Medications: An Examination of Between-Medication Differences
Wilson I, Tchetgen E, Spiegelman D. Patterns of Adherence With Antiretroviral Medications: An Examination of Between-Medication Differences. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 259-263. DOI: 10.1097/00126334-200111010-00009.Peer-Reviewed Original ResearchAntiretroviral medicationsAdherence issuesPatient differencesLast weekMore antiretroviral medicationsPercent of patientsPatterns of adherencePatient adherence issuesRepeated-measurements analysisCohort studyHIV infectionAntiretroviral adherenceAdherence ratesMean ageOverall adherenceMedicationsPatientsAdherence patternsPerfect adherencePerson varianceDosing timeAdherenceWeeksDoseReliability coefficients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply